Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer

Abstract

This multimodal treatment of locally advanced gastric cancer provides reasonable 3-year survival compared with historical data, but at a considerable cost in terms of morbidity and mortality.